DR. O'FLAHERTY & PARTNERS
GLENDERMOTT MEDICAL, GLENDERMOTT MEDICAL, WATERSIDE HEALTH CENTRE, 127 SPENCER ROAD, LONDONDERRY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 9 | 12 | 75.0% | |
| HF 4 | 2011 | 13 | 16 | 81.2% | |
| HF 4 | 2012 | 12 | 13 | 92.3% | |
| HF 4 | 2013 | 13 | 13 | 100.0% | |
| HF004 | 2014 | 12 | 15 | 80.0% | |
| HF004 | 2015 | 8 | 9 | 88.9% | |
| HF004 | 2016 | 8 | 9 | 88.9% | |
| HF004 | 2017 | 40 | 47 | 85.1% | |
| HF004 | 2018 | 30 | 35 | 85.7% | |
| HF004 | 2019 | 28 | 33 | 84.8% | |
| HF004 | 2020 | 28 | 32 | 87.5% | |
| HF004 | 2021 | 33 | 37 | 89.2% |
